Telix Pharmaceuticals Limited (ASX:TLX)
14.81
+0.25 (1.72%)
At close: Dec 5, 2025
Telix Pharmaceuticals Employees
Telix Pharmaceuticals had 234 employees as of December 31, 2022. The number of employees increased by 76 or 48.10% compared to the previous year.
Employees
234
Change (1Y)
76
Growth (1Y)
48.10%
Revenue / Employee
2.40M AUD
Profits / Employee
39.10K AUD
Market Cap
5.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 234 | 76 | 48.10% |
| Dec 31, 2021 | 158 | 149 | 1,655.56% |
| Dec 31, 2017 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 29,904 |
| Pro Medicus | 132 |
| Cochlear | 5,500 |
| Sonic Healthcare | 45,000 |
| Ramsay Health Care | 90,000 |
| Ansell | 15,000 |
| Mesoblast | 81 |
| Neuren Pharmaceuticals | 8 |
Telix Pharmaceuticals News
- 19 hours ago - TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain - PRNewsWire
- 20 hours ago - TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewsWire
- 1 day ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. Lawsuit – TLX - GlobeNewsWire
- 1 day ago - TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain - GlobeNewsWire
- 1 day ago - TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX - GlobeNewsWire
- 1 day ago - Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 1 day ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals - GlobeNewsWire
- 1 day ago - The Gross Law Firm Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX - PRNewsWire